🔗 Permalink

Inventor profile of:

Davide RADZIK

City:

Paris

Country:

France

Published Applications:

Last publication date:

2021-09-02

Top Assignees for applications by Davide RADZIK

The entities that hold a legal rights for patent applications filed by inventor RADZIK Davide:

SANOFI-AVENTIS 9 Paris, France
SANOFI 7 Paris, France

Recent patent applications by RADZIK Davide

Davide RADZIK from Paris, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-09-02

US20210267931A1

Human necessities

USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR OF MORTALITY

#2 | 2019-02-14

US20190046496A1

Human necessities

USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR OF MORTALITY

#3 | 2017-09-28

US20170273936A1

Human necessities

USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR OF MORTALITY

#4 | 2015-11-19

US20150328181A1

Human necessities

USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR OF MORTALITY

#5 | 2014-03-27

US20140088189A1

Human necessities

METHODS FOR REDUCING THE RISK OF AN ADVERSE DRONEDARONE / BETA-BLOCKERS INTERACTION IN A PATIENT SUFFERING FROM ATRIAL FIBRILATION

#6 | 2013-08-22

US20130217763A1

Human necessities

Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of morality

#7 | 2013-05-09

US20130116586A1

Human necessities

USE OF DRONEDARONE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR THE PREPARATION OF A DRUG FOR THE PREVENTION OF ATRIAL FIBRILLATION

#8 | 2012-12-27

US20120329867A1

Human necessities

USE OF DRONEDARONE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, FOR THE PREPARATION OF A MEDICAMENT FOR ADMINISTRATION SHORTLY AFTER AMIODARONE DISCONTINUATION

#9 | 2012-01-05

US20120005128A1

Human necessities

METHODS FOR REDUCING THE RISK OF AN ADVERSE DRONEDARONE / CALCIUM CHANNEL BLOCKERS INTERACTION IN A PATIENT SUFFERING FROM ATRIAL FIBRILATION

#10 | 2012-01-05

US20120000806A1

Human necessities

Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation

#11 | 2011-09-22

US20110230552A1

Human necessities

USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION OF STROKE OR TRANSIENT ISCHEMIC ATTACK

#12 | 2011-09-15

US20110224293A1

Human necessities

USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR OF MORTALITY

#13 | 2011-09-01

US20110213027A1

Human necessities

USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR OF MORTALITY

#14 | 2011-08-25

US20110207811A1

Human necessities

USE OF CELIVARONE FOR REDUCING OCCURRENCES OF CARDIOVASCULAR HOSPITALIZATION

#15 | 2011-07-07

US20110166221A1

Human necessities

USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVERSION

#16 | 2011-07-07

US20110166220A1

Human necessities

DRONEDARONE FOR THE PREVENTION OF PERMANENT ATRIAL FIBRILLATION

#17 | 2011-06-09

US20110136899A1

Human necessities

COMBINATION OF DRONEDARONE WITH AT LEAST ONE DIURETIC, AND THERAPEUTIC USE THEREOF

#18 | 2011-05-26

US20110124724A1

Human necessities

USE OF DRONEDARONE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, FOR THE PREPARATION OF A MEDICAMENT FOR REGULATING THE POTASIUM LEVEL IN THE BLOOD

#19 | 2010-02-25

US20100048694A1

Human necessities

Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality

InventorID:

237116 ⎘